A study looking at nivolumab with temozolomide and radiotherapy for people with a glioblastoma (CA209548)

Please note

This trial is no longer recruiting patients. We hope to add results when they are available.

Overview

Cancer types:

Brain (and spinal cord) tumours

Status:

Closed

Phase:

Phase 2

Details

This study is for people with a newly diagnosed glioblastoma who have not had any treatment apart from surgery. Glioblastoma is the most common type of brain tumour in adults.

People will be asked to take part in this study if they have already agreed to take part in another study (CA209-498). But they were not eligible to continue with the CA209-498 study.

Recruitment start: 9 May 2016

Recruitment end: 31 July 2018